Mycoplasma pneumoniae is responsible for community-acquired respiratory tract infections, such as tracheobronchitis and pneumonia, particularly in school-aged children and young adults. These infections occur both endemically and epidemically at 3- to 7-year intervals worldwide. Numerous extra-respiratory manifestations of variable severity have also been associated with M. pneumoniae infections including dermatological manifestations and neurological complications.